Khan Mubashir Ahmad, Mohamed Amr M, Faiz Aftab, Ahmad Jawwad
Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al Qura University, Makkah, Saudi Arabia.
Microbiology Department, Maternity and Children hospital, Makkah, Saudi Arabia.
J Infect Dev Ctries. 2019 Apr 30;13(4):334-341. doi: 10.3855/jidc.11056.
Carbapenemase producing Enterobacteriaceae are emerging as important pathogens worldwide with serious effects on patients' outcome. The study aimed to investigate the emergence of carbapenemases associated with enterobacterial infection in Western region of Saudi Arabia.
Clinical isolates from suspected patients with enterobacterial infection were investigated over a one-year period from four tertiary care hospitals of Makkah, Saudi Arabia. All isolates were identified using Vitek-2 system and then screened for potential carbapenemase production using disk diffusion test. Suspected isolates with reduced susceptibility to carbapenems were further investigated for blaNDM-1, blaKPC and blaOXA-48 resistant genes.
Out of 120 confirmed Enterobacteriaceae isolates, Klebsiella pneumoniae and Escherichia coli comprised the largest proportion (35% and 34.2%, respectively) of encountered infections. Twenty-six (21.7%) isolates showed resistance to carbapenems, the majority of which (21/26) were K. pneumoniae. Remarkably, 17 isolates carried triple resistant genes KPC/NDM-1/OXA-48 while the other 4 carried double resistant genes (KPC/OXA-48) or (NDM-1/OXA-48). The current study revealed that the mentioned triple resistance genes have the higher incidence with significant association risk among males (COR 4.5; CI: 1.9-17.3; P = 0.018), non-Saudi nationalities (COR 4.9; CI: 1.5-19.3; P = 0.003), ICU-obtained specimens (COR 3.6; CI: 1.5-8.4; P = 0.002) and blood specimens (COR 2.8; CI: 1.1-6.9; P = 0.02).
Multidrug-resistant Enterobacteriaceae isolates in particular K. pneumoniae co-harboring KPC, NDM-1 and OXA-48 genes are emerging in Western region, Saudi Arabia. This is the first record of triple carbapenemase genes co-producing K. pneumoniae associated with enterobacterial infection.
产碳青霉烯酶肠杆菌科细菌正在成为全球重要的病原体,对患者的治疗结果产生严重影响。本研究旨在调查沙特阿拉伯西部地区与肠杆菌感染相关的碳青霉烯酶的出现情况。
在沙特阿拉伯麦加的四家三级护理医院,对疑似肠杆菌感染患者的临床分离株进行了为期一年的调查。所有分离株均使用Vitek-2系统进行鉴定,然后使用纸片扩散法筛选潜在的碳青霉烯酶产生情况。对碳青霉烯类药物敏感性降低的疑似分离株进一步检测blaNDM-1、blaKPC和blaOXA-48耐药基因。
在120株确诊的肠杆菌科分离株中,肺炎克雷伯菌和大肠埃希菌在感染中所占比例最大(分别为35%和34.2%)。26株(21.7%)分离株对碳青霉烯类药物耐药,其中大多数(21/26)为肺炎克雷伯菌。值得注意的是,17株携带KPC/NDM-1/OXA-48三重耐药基因,另外4株携带双重耐药基因(KPC/OXA-48)或(NDM-1/OXA-48)。当前研究表明,上述三重耐药基因在男性(优势比4.5;可信区间:1.9-17.3;P = 0.018)、非沙特国籍人群(优势比4.9;可信区间:1.5-19.3;P = 0.003)、重症监护病房获得的标本(优势比3.6;可信区间:1.5-8.4;P = 0.002)和血液标本(优势比2.8;可信区间:1.1-6.9;P = 0.02)中的发生率较高,且具有显著的关联风险。
多重耐药肠杆菌科分离株,特别是同时携带KPC、NDM-1和OXA-48基因的肺炎克雷伯菌,正在沙特阿拉伯西部地区出现。这是首次记录到与肠杆菌感染相关的产三重碳青霉烯酶基因的肺炎克雷伯菌。